节点文献

新型重组人肿瘤坏死因子-α对四氯化碳及刀豆蛋白A诱导小鼠肝损伤的影响

Effects of novel recombinant human tumor necrosis factor α (nrhTNFα) on liver injury induced by carbon tetrachloride or Concanavalin A

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 石传群吴勇杰高明堂李文广臧凯宏李智勤

【Author】 SHI Chuan qun, WU Yong jie, GAO Ming tang, LI Wen guang,ZANG Kai hong, LI Zhi qin College of Pharmaceutical Science of Lanzhou University, Key Laboratory of Preclinical Study for New Traditional Chinese Medicine of Gansu Province Lanzhou, 730000, Gansu, China

【机构】 兰州大学药学院甘肃省中药新药临床前研究重点实验室甘肃省中药新药临床前研究重点实验室 兰州730000甘肃兰州730000甘肃

【摘要】 目的 :研究不同剂量的新型重组人肿瘤坏死因子 (nrhTNFα)对肝功能及肝脏组织形态学的影响。方法 :用四氯化碳 (CCl4)或刀豆蛋白A(ConA)诱导小鼠肝损伤 ,nrhTNFα低、中、高剂量 (5× 10 4,5×10 5,5× 10 6IU·kg-1)im ,测血清中ALT、AST、LDH、IFN α、IL 2和NO浓度变化 ,检查肝脏组织形态学变化。结果 :3个剂量的nrhTNFαim对正常小鼠肝功能及肝脏组织形态学无影响 ;低、中剂量nrhTNFα对CCl4诱导肝损伤小鼠的肝功能及肝脏组织形态学无影响 ,高剂量nrhTNFα加重肝损伤 ;3个剂量的nrhTNFα降低ConA诱导的肝损伤小鼠血清ALT、AST、LDH和IFN γ浓度增加 ,且nrhTNFα低剂量作用明显 ,能明显减轻肝脏病理学改变。结论 :nrhTNFα低、中、高剂量im对正常小鼠无肝毒性 ;nrhTNFα低、中剂量im不影响CCl4诱导的肝损伤 ,高剂量则加重之 ;3个剂量的nrhTNFαim抑制ConA诱导的肝损伤 ,其作用机理与抑制ConA诱导的小鼠IFN γ产生有关。

【Abstract】 AIM: To investigate the effects of different doses of nrhTNFα on liver function and liver histological morphology and explore its mechanism. METHODS: Liver injury was induced by CCl 4 or Concanavalin A (Con A) in mice. nrhTNFα(IU·kg -1 )was injected intramuscularly at low(5×10 4), median(5×10 5), and high doses(5×10 6).Changes of serum ALT, AST, LDH, IFN γ, IL 2 and NO levels were detected. Liver histological changes were examined accordingly. RESULTS: The nrhTNFα had no effect on the liver function and liver histological morphology in intact mice at above three doses groups. The nrhTNFα also had no effect on the liver function and liver histological morphology in the CCl 4 treated mice at the low and median doses groups, but liver damage was exacerbated at the high dose group in this model. The increased concentrations of serum ALT, AST, LDH and IFN γ levels in the Con A treated mice were diminished with three doses groups, especially at the low dose group. A significant improvement was observed in pathohistology examination in this model at above three doses groups. CONCLUSION: The nrhTNFα im has no hepatic toxicity in intact mice at above three doses groups. The low and median doses of nrhTNFα im have no impact on the liver injury in the CCl 4 treated mice. The high dose of nrhTNFα im exacerbates the liver injury in this model. The nrhTNFα inhibits the liver injury in the Con A treated mice. Its mechanisms may be related to the inhibition of the production of IFN γ in this model.

  • 【文献出处】 中国临床药理学与治疗学 ,Chinese Journal of Clinical Pharmacology and Therapeutics , 编辑部邮箱 ,2005年02期
  • 【分类号】R96
  • 【被引频次】4
  • 【下载频次】193
节点文献中: 

本文链接的文献网络图示:

本文的引文网络